bioRxiv
A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer
Publication
, Preprint
Ware, K; Thomas, B; Olawuni, P; Sheth, M; Hawkey, N; Yeshwanth, M; Miller, B; Vietor, K; Jolly, MK; Kim, SY; Armstrong, A; Somarelli, J
2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Ware, K., Thomas, B., Olawuni, P., Sheth, M., Hawkey, N., Yeshwanth, M., … Somarelli, J. (2022). A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. bioRxiv. https://doi.org/10.1101/2022.11.15.516649
Ware, Kathryn, Beatrice Thomas, Pelumi Olawuni, Maya Sheth, Nathan Hawkey, M. Yeshwanth, Brian Miller, et al. “A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer.” BioRxiv, 2022. https://doi.org/10.1101/2022.11.15.516649.
Ware K, Thomas B, Olawuni P, Sheth M, Hawkey N, Yeshwanth M, et al. A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. bioRxiv. 2022.
Ware, Kathryn, et al. “A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer.” BioRxiv, 2022. Epmc, doi:10.1101/2022.11.15.516649.
Ware K, Thomas B, Olawuni P, Sheth M, Hawkey N, Yeshwanth M, Miller B, Vietor K, Jolly MK, Kim SY, Armstrong A, Somarelli J. A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. bioRxiv. 2022.